Here’s What’s Really Happening with Aphria’s Stellar Earnings Report

Aphria Inc. (NYSE: APHA) reported its fiscal fourth-quarter earnings last week, and the company exceeded all expectations.

And it beat those estimates from underneath a cloud of short sellers’ spurious innuendo, to boot.

After a quarter of overall decline in Canadian cannabis revenue, Aphria saw an increase of 85% – that’s 85% sequentially and not year over year. The company also turned earnings before interest, tax, depreciation, and amortization (EBITDA) positive – albeit after adjustments and with help from a European pharmaceutical distribution business the company owns.

And to top it off, management’s optimistic about the future.

So any investor could look at Aphria’s reporting and conclude it had a great quarter. And they’d be dead on.

What might not be so obvious at first glance is that this company just showed investors how it was going to take the cannabis sector to the next level.

There’s much more here than meets the eye…

Aphria Is Speeding in the Right Direction

From this earnings report, it’s painfully clear that the Canadian producers were nowhere near ready for October 2018 legalization.

Folks got caught with their britches down, frankly, and the blame for the ongoing cannabis shortage in Canada has been directed at a lot of targets – producers, regulators, and retailers.

THREE STOCKS: Any one of these cannabis companies could potentially deliver a 1,000% windfall. Click here to learn more

Each probably deserves some blame, and in particular, the huge delays in Ontario retail stores hurt the industry. But it’s clear now that the producers may have been a little too confident in how much marijuana they could produce.

As companies like Aphria get better at growing cannabis, they will get better at meeting demand.

Aphria shipped more than double the amount of cannabis this quarter than it did just three months ago, and CEO Irwin Simon attributed the success to recent changes the company made in how it produces cannabis.

It’s all in advance of something we’ll call “Canada 2.0.” And that’s coming in December.

The Market North of the Border Will Expand Massively

Come December, Canada should be allowing the sale of “vapes” (cannabis concentrates and extracts that can be vaporized, as opposed to smoked) and edible cannabis products.

In an interview after the call, Aphria CEO Simon claimed that there was already a $1 billion market for vapes in Canada. Trouble is, it’s an illicit market at the moment.

Simon actually described that black market as his biggest competitor.

So when legal industry begins to offer vapes and edibles as legal products, we’re almost assured of significant sales increases in December and the first quarter of 2020. All the while, these companies will be growing adequate supplies of cannabis.

Marijuana Stock Prices Are Ready to Rocket

The weed market wants to go up. But it has to climb a classic “wall of worry” before it can do that. In relatively short order, we’ve seen the scandal at CannTrust, and a U.S. Food & Drug Administration warning letter land an American cannabidiol (CBD) producer. We’ve even seen Canopy Growth Corp. (NYSE: CGC) – a heavyweight pot stock – fire CEO Bruce Linton.

Aphria itself was under attack not long ago, when some short-sellers made serious – but ultimately disproven – allegations in a bid to drive the share price their way. (Those bear raiders are now wishing they hadn’t; short Aphria positions are closing left and right!)

SIT THIS ONE OUT and you could miss an American economic revolution that could send three little pot stocks soaring up to 1,000%. Click here to see why

These are relatively minor problems – especially when you compare them to the derivatives double-dealing at “too big to fail” American banks, say, or the Volkswagen emissions scandal. It’s just that the cannabis sector is so new, these few issues have been enough to scare investors off.

But Aphria’s results remind us all why we are invested in cannabis…

No one else grows revenue 85% in a single quarter.

Aphria’s move of more than 30% following the earnings beat is impressive, but other rallies have been equally fast. The market increased by 80% in a month after Constellation Brands Inc. (NYSE: STZ) invested in Canopy.

When cannabis stocks recover, it will happen very quickly. Make sure you’re in position to profit.

We’re Letting You In on a Secret Cannabis Investing Strategy

Less than a year ago, Wall Street opened up Cannabis Lots – but that’s not something that anyone will be knocking down your door to tell you anytime soon.

That’s why we’ve partnered with one of the top experts in this field to spill the details on this investing phenomenon – he’s even been called America’s No. 1 Pattern Trader!

Using his patented system, his data has shown more than 10 times larger payouts than ordinary stock trading.

To get this sort of profit power for yourself, check this presentation out now.

Follow Money Morning onFacebook and Twitter.

About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and visitors become smarter, more confident investors.To get full access to all Money Morning content, click here.

Disclaimer: © 2019 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201.